Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02260596 · ClinicalTrials.gov registry record
Respiratory Viral Infections in Pediatric Transplantation
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,669
- Enrollment target
NCT02260596: Completed study, sponsored by Duke University.
NCT02260596 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,669 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02260596 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,669 participants
- Enrollment target
Study Summary
A retrospective cohort of solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients will be assembled to determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develop a respiratory viral infection within one year of transplantation will be leveraged to investigate factors associated with mortality in the three months after respiratory viral infection.
Primary Outcome
Pediatric SOT/HSCT recipients who do not develop respiratory viral infection within 1 year following transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,669 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
What the finished NCT02260596 record still lists
NCT02260596 is an observational study that tracks outcomes without assigning an intervention. Its 2,669 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02260596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02260596 about?
NCT02260596 is a clinical study titled "Respiratory Viral Infections in Pediatric Transplantation". A retrospective cohort of solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients will be assembled to determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develo...
What is the current status of trial NCT02260596?
This trial is currently completed. The enrollment target is 2,669 participants. The study started on 2014-09. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02260596?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia